Story perspectives

K.C. Pharmaceuticals Recalls 3.1M Eye Drops Over Sterility Concerns

4/6/2026

Summary

Story summary

K.C. Pharmaceuticals recalled 3.1 million eye drop bottles for sterility concerns, a Class II recall confirmed by U.S. Food and Drug Administration (FDA).
The recall covers formulations at CVS and Walgreens.
Consumers should check expiration dates into 2026 to identify affected products.
No injuries have been reported in connection with this recall.
The U.S. FDA notes past recalls linked to infections and vision loss and will monitor eye drop safety.

1 of 1

Story summary

K.C. Pharmaceuticals recalled 3.1 million eye drop bottles for sterility concerns, a Class II recall confirmed by U.S. Food and Drug Administration (FDA).
The recall covers formulations at CVS and Walgreens.
Consumers should check expiration dates into 2026 to identify affected products.
No injuries have been reported in connection with this recall.
The U.S. FDA notes past recalls linked to infections and vision loss and will monitor eye drop safety.